Evidence map›Paper›PMID 40771366›Full record

ArticleCase reports in oncology

Late-Onset Bilateral Retinoblastoma in Adolescence with Successful Globe Salvage.

Shreyas Temkar, Nirupama Kasturi, Amit Kumar Deb, Hemanth Ramachandar, Krishna Murali, Renu Puthenvilayil Rajan

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shreyas TemkarDepartment of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Nirupama KasturiDepartment of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Amit Kumar DebDepartment of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Hemanth RamachandarDepartment of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Krishna MuraliDepartment of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Renu Puthenvilayil RajanRetina and Vitreous Services, Aravind Eye Hospital, Madurai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Retinoblastoma (RB) is the most common intraocular malignancy in children, known to occur within 5 years of age. The occurrence of RB after the first decade of life is rare and is usually unilateral. Owing to its varied and delayed presentation with advanced stages, enucleation is advocated in most cases of late-onset RB. However, with the advent of multiple treatments, such as local therapies, the chances of globe salvage can still be attempted, even in late-onset RB. Case Presentation: We report a case of a 14-year-old boy who had active RB in the right eye and retinomas in the left eye. The child was given systemic three-drug chemotherapy (standard VEC regimen) along with intravitreal injection of topotecan for vitreous seeds in the right eye and cryotherapy for the retinomas in the left eye. By 1 year, the right eye lesion had shown stable type II regression and no recurrence of vitreous seeds, while the left eye lesions showed type IV regression. Conclusion: This case highlights a case of bilateral late-onset RB with a rare combination of active RB in one eye and retinoma in the other eye. Successful globe salvage was achieved by combining local and systemic approaches, resulting in good anatomical and functional outcomes.

Indexed as

ChemotherapyGeneticsOcular malignancyRetinoblastoma

Identifiers

PMID40771366
PMCPMC12327929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.